Get Live Data

Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses
Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licensesView Video

Latest Share Chat

  2. Share Prices
  3. Hutchmed Share Price
  4. Hutchmed Share Regulatory News

Pin to quick picksHutchmed Regulatory News (HCM)

Hutchmed Information

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 312.00
Bid: 301.00
Ask: 310.00
Change: 8.00 (2.63%)
Spread: 9.00 (2.99%)
Open: 312.00
High: 312.00
Low: 312.00
Prev. Close: 304.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

6789101112131415
Date   Source Headline
23rd Mar 201610:34 amRNSHolding(s) in Company
22nd Mar 20162:00 pmRNSClosing of U.S. Public Offering of ADSs
21st Mar 20168:54 amRNSDirector/PDMR Shareholding
21st Mar 20167:00 amRNSSulfatinib Phase III registration study
18th Mar 20164:18 pmRNSFinal Prospectus
17th Mar 20167:00 amRNSPricing of U.S. Public Offering of ADSs
15th Mar 20167:00 amRNS2015 Annual Report and Notice of AGM
7th Mar 20167:59 amRNSFifth Filing of Form F-1 Registration Statement
4th Mar 20166:12 pmRNSLaunch of Potential U.S. Public Offering of ADSs
4th Mar 20165:54 pmRNSFifth Filing of Form F-1 Registration Statement
2nd Mar 20167:00 amRNSSulfatinib Phase II initation in thyroid cancer
1st Mar 20164:29 pmRNSFourth Filing of Form F-1 Registration Statement
1st Mar 20167:00 amRNSFinal Results
11th Feb 20165:39 pmRNSPublic Filing of Form F-1 Registration Statement
29th Jan 20168:03 amRNSNotice of Results
15th Jan 20167:02 amRNSChi-Med initiates HMPL-523 Phase I clinical trial
29th Dec 20157:43 amRNSBlocklisting Six Monthly Return
18th Dec 20157:00 amRNSInitiation sulfatinib Phase III registration study
9th Dec 20157:00 amRNSUS$105 m Shanghai land compensation agreement
8th Dec 20157:00 amRNSInitiation of fruquintinib Phase 3 trial in NSCLC
13th Nov 20152:50 pmRNSSecond Public Filing of Registration Statement
10th Nov 20151:13 pmRNSResults of Extraordinary General Meeting
9th Nov 20157:59 amRNSDirector/PDMR Shareholding
6th Nov 20157:00 amRNSChi-Med initiates sulfatinib U.S. clinical trials
30th Oct 20157:00 amRNSClinical results presented
30th Oct 20157:00 amRNSTotal Voting Rights
30th Oct 20157:00 amRNSCompletion of Phase I clinical trial of HMPL 523
20th Oct 20152:40 pmRNSDirector's Share Dealing
19th Oct 20157:00 amRNSAwards under Long Term Incentive Plan
16th Oct 201512:17 pmRNSShareholders' Circular and Notice of EGM
16th Oct 201512:15 pmRNSFiling of Registration Statement on Form F1
16th Oct 201512:03 pmRNSChi-Med files Nasdaq Registration Statement
13th Oct 20157:00 amRNSEnrolment complete in Savolitinib Phase II trial
12th Oct 20152:09 pmRNSHolding(s) in Company
14th Sep 20157:00 amRNSPresentation at 2015 European Cancer Congress
2nd Sep 201511:57 amRNSTrial of fruquintinib achieves primary endpoint
19th Aug 201512:14 pmRNSTermination of R&D agreement with Janssen
28th Jul 20157:00 amRNSInterim Results
23rd Jul 20151:05 pmRNSNotification of major interest in shares
23rd Jul 20151:01 pmRNSNotification of major interest in shares
23rd Jul 20159:01 amRNSMitsui exchanges shares in Hutchison MediPharma
17th Jul 20157:00 amRNSInvention patent granted for SXBXP
6th Jul 20157:00 amRNSNotice of Announcement of 2015 Interim Results
29th Jun 20157:00 amRNSBlocklisting Six Monthly Return
1st Jun 20157:00 amRNSSavolitinib preliminary Phase Ib data presented
13th May 20157:00 amRNSFruquintinib results trigger payments from Lilly
30th Apr 20157:00 amRNSTotal Voting Rights
24th Apr 201512:40 pmRNSResult of AGM
22nd Apr 201511:23 amRNSDirector/PDMR Shareholding
16th Apr 20151:19 pmRNSDirector's Shareholding
6789101112131415

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.